Training Program in Drug Dependence Epidemiology

描述(由申请人提供)：本提案是为位于密歇根州立大学人类医学院流行病学系内的NIH/NIDA药物依赖流行病学培训计划(DDETP)提供的为期5年的更新机构T32 NRSA支持。DDETP创始人/培训项目主任是James C.(Jim)Anthony教授，他在2003至2010年间的NIDA K05高级科学家工作包括创建密歇根州立大学DDETP，基于他在约翰·霍普金斯大学成功实施DDETP的模型(1990-2003)，为此他获得了三项导师奖。同时领导该项目的还有流行病学教授Naomi Breslau，以及代表流行病学/生物统计学、一般定量方法学、临床科学/治疗学、行为遗传学、临床前/临床药理学以及相关领域(如社会学、社会工作、家庭治疗)的跨学科MSU教员。DDETP的主要目标是在相关领域增加数量熟练的流行病学家和研究人员的数量和质量，他们的职业承诺是致力于NIDA预防和控制药物依赖综合征和相关的精神活性药物使用的可疑危险的使命。建议的3名NIDA博士前实习生首先完成2-3年的学徒研究课程，通过资格考试以确定博士候选人资格，然后完成2-3年的研究，然后完成2-3年的研究，最后为一篇专著长度的论文辩护，该论文代表了NIDA流行病学研究背景下需要统计估计或正式假设检验的新科学证据的重大贡献。拟议的3名0、3和7级博士后学员完成药物依赖流行病学研究生研究培训的个别化方案，为期1-3年(主要是1-2年)，在NIDA研究中有更大的时间平衡。这两种类型的受训人员都完成了必要的诚信和道德培训，并努力在该领域的期刊上收集第一篇和共同撰写的文章，草稿 他们自己的研究人员发起的NIDA奖励申请，以及适当的K型职业发展计划。该计划旨在应对六个挑战：(1)加强多样性推广，(2)与密歇根州立大学新的NIH临床转化研究和培训计划更好地整合，包括艾滋病毒/艾滋病研究，(3)关于项目管理和通往健康科学和联邦机构管理、小企业和行业研究(例如NIDA SBIR和STTR)的非学术职业道路的新教育模块，(4)使用NIH和NIDA在线职业跟踪计划，以及评估指导过程的在线调查，(5)打造新的解决方案，以解决最近受到赞赏的“漂移”过程，该过程现在损害了项目后在竞争激烈的研究资助环境中的成功，以及(6)培养新一代项目的主要顾问学院(PAF)成员，以促进项目在拟议的续签获奖期及以后的成功。

DESCRIPTION (provided by applicant): This proposal is for 5 years of renewed institutional T32 NRSA support for the NIH/NIDA Drug Dependence Epidemiology Training Program (DDETP) located within Michigan State University College of Human Medicine Department of Epidemiology. DDETP founder/training program director is Professor James C. (Jim) Anthony, whose NIDA K05 Senior Scientist work between 2003 and 2010 included creation of the MSU DDETP, based upon his model for a successful DDETP at Johns Hopkins University (1990-2003), for which he received three mentoring awards. Also leading the program is Epidemiology Professor Naomi Breslau, and there is an interdisciplinary MSU faculty who represent epidemiology/biostatistics, quantitative methodology generally, clinical sciences/therapeutics, behavioral genetics, preclinical/clinical pharmacology, and allied fields (e.g., sociology, social work, family therapy). The main DDETP goal is to increase the number and quality of quantitatively adept epidemiologists and researchers in allied fields whose career commitment is toward NIDA's mission to prevent and control drug dependence syndromes and related suspected hazards of psychoactive drug use. The proposed 3 NIDA predoctoral trainees first complete 2-3 years of coursework with research apprenticeships, pass qualifying exams to establish candidacy for the PhD, and then complete 2-3 years of research before final defense of a monograph-length dissertation representing significant contributions of new scientific evidence that requires statistical estimation or formal hypothesis-testing in the NIDA epidemiology research context. The proposed 3 postdoctoral trainees at Levels 0, 3, & 7 complete an individualized program of postgraduate research training in drug dependence epidemiology, of 1-3 years duration (mostly 1-2 years), with a greater balance of time in NIDA research. Both types of trainees complete required integrity and ethics training, and work to assemble a portfolio of first-authored and co-authored articles in journals of the field, drafts of their own investigator-initiated NIDA grant award applications, and K-type career development plans, when appropriate. The program plan is designed to meet six challenges: (1) enhancing diversity outreach, (2) greater integration with MSU's new NIH clinical translational research and training initiatives, including HIV/AIDS research, (3) new educational modules on project management and on non-academic career paths toward health science and federal agency administration, small business and industry research (e.g., NIDA SBIR & STTR), (4) use of NIH and NIDA online career tracking programs, as well as online surveys to assess the mentoring process, (5) forging new solutions to a recently appreciated 'drift away' process that now detracts from post-program success in a competitive research funding environment, and (6) cultivation of a new generation of the program's Primary Advising Faculty (PAF) members in order to promote the success of the program during the proposed renewal award period and beyond.